EUVIMED · CrossrefZeitschrift
Nature Reviews Cancer
ISSN 1474-175X · Springer Science and Business Media LLC
Neueste Artikel
Beyond the tumour: circulating extracellular matrix fragments as next-generation cancer biomarkers
3D models to capture and perturb tumour heterogeneity in vitro
Origins and heterogeneity of colorectal cancer
Astrocytes drive stroke-induced glioma progression
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response
Epigenetic changes linked to cell replication connect ageing with cancer risk
3D multi-omics tumour atlases: from technology to biology and clinical translation
Igniting antitumour immunity with cancer cell pyroptosis
Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity
The DNA damage response and cancer immunotherapy
Stem cells as an essential mediator of the exercise–tumorigenesis link
Regulation of immune checkpoint molecules in cancer immune evasion and therapy
Beyond sex determination: the Y chromosome in male cancers
Mesenchymal stromal/stem cells in tumour initiation, progression and therapy
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research
The sleeping threat: targeting cancer dormancy to transform metastasis therapy
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Striking the right balance with type I interferon signalling in cancer
Rethinking ovarian cancer III: the past decade and future directions
Remembering inflammation increases cancer risk
Artificial intelligence-generated synthetic data for cancer research and clinical trials
Claudin proteins as emerging therapeutic targets for solid tumours
Artificial intelligence agents in cancer research and oncology
Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy
Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment
Targeting macropinocytosis for cancer therapy
Targeting phagocytosis checkpoints for cancer immunotherapy
Opportunities and challenges of targeting cGAS–STING in cancer
Convergence of machine learning and genomics for precision oncology
A guide to transcriptomic deconvolution in cancer
EUVIMED